Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-018410
Filing Date
2021-05-05
Accepted
2021-05-05 18:50:08
Documents
1
Period of Report
2021-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4115
  Complete submission text file 0000899243-21-018410.txt   5503
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Issuer) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SURFACE ONCOLOGY, INC. 50 HAMPSHIRE STREET 8TH FL CAMBRIDGE MA 02139
Business Address
RATH HENRY C. (Reporting) CIK: 0001859736 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38459 | Film No.: 21895090